Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Decides On Rights Issue Of Units And Warrants Of About SEK 90 Mln

Oct 13 (Reuters) - Kancera  KANC.ST :
    * SAID ON WEDNESDAY IT HAS DECIDED ON RIGHTS ISSUE OF UNITS
AND
WARRANTS OF ABOUT SEK 90 MLN
    * SUBSCRIPTION PRICE AT SEK 24 PER UNIT
    * AIM OF THE ISSUE IS TO INTENSIFY INVESTMENT IN CLINICAL
DEVELOPMENT FOR THE TREATMENT OF OVARIAN CANCER

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkrw4q1j
 Further company coverage:  KANC.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Novakand Pharma AB

See all news